Tanibirumab (TTAC-0001): A fully human monoclonal antibody targets vascular endothelial growth factor receptor 2 (VEGFR-2)
2011 ◽
Vol 34
(8)
◽
pp. 1223-1226
◽
2015 ◽
Vol 33
(15_suppl)
◽
pp. 2522-2522
◽
2017 ◽
Vol 35
(6)
◽
pp. 782-790
◽
2013 ◽
Vol 32
(2)
◽
pp. 303-311
◽
2008 ◽
Vol 6
(12)
◽
pp. 127-128
2014 ◽
Vol 30
(10)
◽
pp. 847-853
◽
2008 ◽
Vol 26
(15_suppl)
◽
pp. 14630-14630
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 5539-5539
◽